(Q51160653)

31 March 2018

title

Desipramine treatment in panic disorder (English)

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

4 December 2022

author name string

O. Kalus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829745

4 December 2022

G. M. Asnis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829745

4 December 2022

E. Rubinson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829745

4 December 2022

R. Kahn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829745

4 December 2022

J. M. Friedman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829745

4 December 2022

N. Iqbal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829745

4 December 2022

D. Grosz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829745

4 December 2022

H. van Praag

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829745

4 December 2022

W. Cahn

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829745

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1829745

4 December 2022

publication date

1 April 1991

1 reference

31 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:016503279190003B?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

https://api.elsevier.com/content/article/PII:016503279190003B?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Journal of Affective Disorders

4 December 2022

published in

1 reference

31 March 2018

volume

21

1 reference

31 March 2018

page(s)

239-244

1 reference

31 March 2018

issue

4

1 reference

31 March 2018

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Placebo response in panic disorder

4 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

A diagnostic interview: the schedule for affective disorders and schizophrenia

4 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Clinical and psychobiological characteristics of simultaneous panic disorder and major depression

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Clomipramine treatment of agoraphobic women. An eight-week controlled trial

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Panic disorder: residual symptoms after the acute attacks abate.

4 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Antidepressants in panic disorder and agoraphobia

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Are there Anticompulsive or Antiphobic Drugs? Review of the Evidence

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Agoraphobia, panic disorder and related conditions in the DSM-IIIR and ICD-10

4 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Imipramine in the treatment of agoraphobia: dose-response relationships

4 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Treatment of panic disorder

4 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Limited-symptom panic attacks.

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Tricyclic antidepressants in the treatment of panic and anxiety disorders.

4 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Research diagnostic criteria: rationale and reliability

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo

4 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0165-0327(91)90003-B

4 December 2022

Identifiers

1 reference

31 March 2018

1 reference

31 March 2018